Literature DB >> 32233289

Vertical transmission of anti-ASFV antibodies as one of potential causes of seropositive results among young wild boar population in Poland.

M Walczak1, M Frant1, M Juszkiewicz1, N Mazur-Panasiuk1, K Szymankiewicz1, M Bruczyńska2, G Woźniakowski1.   

Abstract

The present study attempted to elucidate possible routes leading to the achievement of sero- positive results, among young (aged ≤1 year) wild boar population. In the years 2017-2018, the National Reference Laboratory (NRL) for African swine fever (ASF) in Poland examined nearly 27-thousand wild boar blood samples, collected during an active surveillance of ASF risk zones, for the presence of viral DNA and anti-ASFV antibodies. Out of all the examined samples, 420 were positive. However, in more than half of them (292 samples) antibodies against African swine fever virus (ASFV) were detected, while ASFV DNA was not detected in blood. Out of all 292 seropositive/PCR-negative samples, 126 belonged to young wild boars (aged ≤1 year). For this reason, the NRL in Poland has examined 10 selected seropositive wild boar carcasses to confirm or exclude post-mortem lesions for ASF as well as to investigate the presence of viral DNA in the internal organs. Neither pathological lesions for ASF nor the presence of genetic material of ASFV were found in the examined wild boars. To elucidate this outcomes, following hypotheses about possible reasons of the obtained results were drawn: the presence of convalescent animals, infection of low-virulent ASFV isolate and the vertical transmission of antibodies through the colostrum. Copyright© by the Polish Academy of Sciences.

Entities:  

Keywords:  ASF; African swine fever; Poland; antibodies; immunoglobulins; seropositive; surveillance; wild boar

Mesh:

Substances:

Year:  2020        PMID: 32233289     DOI: 10.24425/pjvs.2019.131415

Source DB:  PubMed          Journal:  Pol J Vet Sci        ISSN: 1505-1773            Impact factor:   0.821


  6 in total

1.  ASF -survivors' Sera Do Not Inhibit African Swine Fever Virus Replication in Vitro.

Authors:  Marek Walczak; Małgorzata Juszkiewicz; Krzesimir Szymankiewicz; Anna Szczotka-Bochniarz; Grzegorz Woźniakowski
Journal:  J Vet Res       Date:  2022-03-25       Impact factor: 2.058

2.  African Swine Fever (ASF) Trend Analysis in Wild Boar in Poland (2014-2020).

Authors:  Maciej Piotr Frant; Anna Gal-Cisoń; Łukasz Bocian; Anna Ziętek-Barszcz; Krzysztof Niemczuk; Anna Szczotka-Bochniarz
Journal:  Animals (Basel)       Date:  2022-05-03       Impact factor: 3.231

3.  Comparative Analysis of Full Genome Sequences of African Swine Fever Virus Isolates Taken from Wild Boars in Russia in 2019.

Authors:  Ali Mazloum; Antoinette van Schalkwyk; Andrey Shotin; Alexey Igolkin; Ivan Shevchenko; Konstantin N Gruzdev; Natalia Vlasova
Journal:  Pathogens       Date:  2021-04-26

4.  Non-Invasive Sampling in the Aspect of African Swine Fever Detection-A Risk to Accurate Diagnosis.

Authors:  Marek Walczak; Anna Szczotka-Bochniarz; Jacek Żmudzki; Małgorzata Juszkiewicz; Krzesimir Szymankiewicz; Krzysztof Niemczuk; Daniel Pérez-Núñez; Lihong Liu; Yolanda Revilla
Journal:  Viruses       Date:  2022-08-11       Impact factor: 5.818

5.  Changes in Estimating the Wild Boar Carcasses Sampling Effort: Applying the EFSA ASF Exit Strategy by Means of the WBC-Counter Tool.

Authors:  Stefano Cappai; Ileana Baldi; Pietro Desini; Antonio Pintore; Daniele Denurra; Marcella Cherchi; Sandro Rolesu; Daniela Mandas; Giulia Franzoni; Mariangela Stefania Fiori; Annalisa Oggiano; Francesco Feliziani; Vittorio Guberti; Federica Loi
Journal:  Viruses       Date:  2022-06-28       Impact factor: 5.818

Review 6.  African Swine Fever in Wild Boar in Europe-A Review.

Authors:  Carola Sauter-Louis; Franz J Conraths; Carolina Probst; Ulrike Blohm; Katja Schulz; Julia Sehl; Melina Fischer; Jan Hendrik Forth; Laura Zani; Klaus Depner; Thomas C Mettenleiter; Martin Beer; Sandra Blome
Journal:  Viruses       Date:  2021-08-30       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.